Comment diagnostique-t-on la paralysie cérébrale ?
Le diagnostic repose sur l'évaluation clinique, l'historique médical et des examens d'imagerie.
Paralysie cérébraleImagerie par résonance magnétique
#2
Quels tests sont utilisés pour le diagnostic ?
Des tests neurologiques, des évaluations motrices et parfois des IRM sont utilisés.
Évaluation neurologiqueImagerie par résonance magnétique
#3
À quel âge peut-on diagnostiquer la paralysie cérébrale ?
Elle peut être diagnostiquée dès l'âge de 6 mois, mais souvent plus tard dans l'enfance.
Paralysie cérébraleDéveloppement de l'enfant
#4
Quels signes précoces indiquent une paralysie cérébrale ?
Des retards dans le développement moteur, une posture anormale ou des mouvements involontaires.
Retard de développementMouvements anormaux
#5
Le diagnostic est-il toujours précis ?
Le diagnostic peut être complexe et nécessite une observation prolongée des symptômes.
Diagnostic médicalSymptômes
Symptômes
5
#1
Quels sont les symptômes courants de la paralysie cérébrale ?
Les symptômes incluent des troubles du mouvement, des spasmes musculaires et des problèmes d'équilibre.
SymptômesTroubles du mouvement
#2
La paralysie cérébrale affecte-t-elle la parole ?
Oui, elle peut entraîner des difficultés de communication et des troubles de la parole.
Troubles de la paroleParalysie cérébrale
#3
Y a-t-il des variations dans les symptômes ?
Oui, les symptômes varient selon le type de paralysie cérébrale et la gravité.
Variabilité des symptômesTypes de paralysie cérébrale
#4
Les enfants atteints ont-ils des problèmes d'apprentissage ?
Certains peuvent avoir des difficultés d'apprentissage, mais cela dépend de chaque cas.
Difficultés d'apprentissageParalysie cérébrale
#5
Les symptômes peuvent-ils s'aggraver avec le temps ?
Les symptômes peuvent évoluer, mais une intervention précoce peut aider à gérer la progression.
Évolution des symptômesIntervention précoce
Prévention
5
#1
Peut-on prévenir la paralysie cérébrale ?
Certaines causes peuvent être évitées, comme les infections pendant la grossesse.
PréventionInfections pendant la grossesse
#2
Quel rôle joue la santé maternelle ?
Une bonne santé maternelle avant et pendant la grossesse réduit le risque de paralysie cérébrale.
Santé maternelleGrossesse
#3
Les soins prénatals sont-ils importants ?
Oui, des soins prénatals réguliers aident à détecter et à gérer les risques potentiels.
Soins prénatalsRisques de grossesse
#4
Comment éviter les traumatismes à la naissance ?
Des soins obstétriques appropriés peuvent réduire le risque de traumatismes à la naissance.
Traumatismes à la naissanceSoins obstétriques
#5
Les vaccinations peuvent-elles aider ?
Oui, certaines vaccinations préviennent des infections qui pourraient causer des dommages cérébraux.
VaccinationsInfections
Traitements
5
#1
Quels traitements sont disponibles pour la paralysie cérébrale ?
Les traitements incluent la physiothérapie, l'orthophonie et parfois des médicaments.
PhysiothérapieTraitement médical
#2
La chirurgie est-elle une option de traitement ?
Oui, la chirurgie peut être envisagée pour corriger des déformations ou améliorer la fonction.
Chirurgie orthopédiqueParalysie cérébrale
#3
Les médicaments peuvent-ils aider ?
Des médicaments peuvent être prescrits pour réduire les spasmes musculaires et la douleur.
MédicamentsSpasmes musculaires
#4
Comment la physiothérapie aide-t-elle ?
La physiothérapie améliore la mobilité, la force et la coordination des mouvements.
PhysiothérapieRéhabilitation
#5
Les traitements sont-ils personnalisés ?
Oui, les traitements sont adaptés aux besoins spécifiques de chaque patient.
Médecine personnaliséePlan de traitement
Complications
5
#1
Quelles complications peuvent survenir ?
Les complications incluent des problèmes respiratoires, des troubles de l'alimentation et des infections.
Complications médicalesTroubles respiratoires
#2
La paralysie cérébrale augmente-t-elle le risque d'autres maladies ?
Oui, elle peut augmenter le risque de maladies comme l'épilepsie et les troubles mentaux.
ÉpilepsieTroubles mentaux
#3
Les complications affectent-elles la qualité de vie ?
Oui, les complications peuvent significativement affecter la qualité de vie des patients.
Qualité de vieComplications
#4
Comment gérer les complications ?
Une approche multidisciplinaire est essentielle pour gérer les complications efficacement.
Gestion des complicationsApproche multidisciplinaire
#5
Les complications sont-elles évitables ?
Certaines complications peuvent être évitées avec un suivi médical approprié et des soins.
Prévention des complicationsSuivi médical
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque ?
Les facteurs incluent des naissances prématurées, des infections et des anomalies génétiques.
Facteurs de risqueNaissance prématurée
#2
L'âge maternel influence-t-il le risque ?
Oui, les femmes plus âgées ont un risque accru de complications pendant la grossesse.
Âge maternelComplications de grossesse
#3
Les jumeaux ont-ils un risque plus élevé ?
Oui, les naissances multiples augmentent le risque de paralysie cérébrale.
Naissances multiplesParalysie cérébrale
#4
Les infections pendant la grossesse sont-elles un risque ?
Oui, certaines infections comme la rubéole peuvent augmenter le risque de paralysie cérébrale.
Infections pendant la grossesseRubéole
#5
Les antécédents familiaux jouent-ils un rôle ?
Oui, des antécédents familiaux de troubles neurologiques peuvent augmenter le risque.
Antécédents familiauxTroubles neurologiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Paralysie cérébrale : Questions médicales les plus fréquentes",
"headline": "Paralysie cérébrale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Paralysie cérébrale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-28",
"dateModified": "2025-02-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Paralysie cérébrale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Encéphalopathies",
"url": "https://questionsmedicales.fr/mesh/D001927",
"about": {
"@type": "MedicalCondition",
"name": "Encéphalopathies",
"code": {
"@type": "MedicalCode",
"code": "D001927",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.140"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Paralysie cérébrale",
"alternateName": "Cerebral Palsy",
"code": {
"@type": "MedicalCode",
"code": "D002547",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Michael Shevell",
"url": "https://questionsmedicales.fr/author/Michael%20Shevell",
"affiliation": {
"@type": "Organization",
"name": "From the Departments of Pediatrics and Neurology/Neurosurgery, McGill University; and Division of Pediatric Neurology, Montreal Children's Hospital-McGill University Health Centre, Canada. michael.shevell@muhc.mcgill.ca."
}
},
{
"@type": "Person",
"name": "Maryam Oskoui",
"url": "https://questionsmedicales.fr/author/Maryam%20Oskoui",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine (JPL), McGill University, Montreal, QC; Department of Pediatrics and Neurology and Neurosurgery (MO, MS), McGill University, Montreal, QC; Centre for Outcomes Research and Evaluation (MO, PN, MS), Research Institute of the McGill University Health Centre, Montreal, QC; Department of Pediatrics (JA), University of Alberta, Edmonton, AB; Janeway Children's Hospital (DB), St. John's, NL; Department of Paediatrics (DF), University of Toronto, Bloorview Research Institute, Toronto, ON; Departments of Pediatrics and Clinical Neurosciences (AK), Cumming School of Medicine, University of Calgary, AB; Centre de réadaptation Marie Enfant du CHU Sainte-Justine (LK), Montreal, QC; Centre hospitalier universitaire de Sherbrooke (NP), Sherbrooke, QC; BC Children's Hospital (EvR), Vancouver, BC; and IWK Health Centre (EW), Halifax, NS, Canada."
}
},
{
"@type": "Person",
"name": "Gija Rackauskaite",
"url": "https://questionsmedicales.fr/author/Gija%20Rackauskaite",
"affiliation": {
"@type": "Organization",
"name": "Paediatric and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark."
}
},
{
"@type": "Person",
"name": "Israt Jahan",
"url": "https://questionsmedicales.fr/author/Israt%20Jahan",
"affiliation": {
"@type": "Organization",
"name": "CSF Global, Dhaka, Bangladesh."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Associations between muscle morphology and spasticity in children with spastic cerebral palsy.",
"datePublished": "2023-01-10",
"url": "https://questionsmedicales.fr/article/36706682",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejpn.2023.01.007"
}
},
{
"@type": "ScholarlyArticle",
"name": "Efficacy of nabiximols oromucosal spray on spasticity in people with multiple sclerosis: Treatment effects on Spasticity Numeric Rating Scale, muscle spasm count, and spastic muscle tone in two randomized clinical trials.",
"datePublished": "2023-05-01",
"url": "https://questionsmedicales.fr/article/37209500",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.msard.2023.104745"
}
},
{
"@type": "ScholarlyArticle",
"name": "Rebalancing the Spastic Wrist by Transposition of Antagonistic Muscle-Tendon Complex.",
"datePublished": "2022-06-01",
"url": "https://questionsmedicales.fr/article/34711790",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/BTH.0000000000000371"
}
},
{
"@type": "ScholarlyArticle",
"name": "Methods of muscle spasticity assessment in children with cerebral palsy: a scoping review.",
"datePublished": "2024-07-11",
"url": "https://questionsmedicales.fr/article/38992701",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13018-024-04894-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Focal muscle spasticity has little impact on muscle power for walking in people with Traumatic Brain Injury.",
"datePublished": "2023-05-03",
"url": "https://questionsmedicales.fr/article/37295342",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clinbiomech.2023.105978"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009422"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies du système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D002493"
},
{
"@type": "ListItem",
"position": 4,
"name": "Encéphalopathies",
"item": "https://questionsmedicales.fr/mesh/D001927"
},
{
"@type": "ListItem",
"position": 5,
"name": "Paralysie cérébrale",
"item": "https://questionsmedicales.fr/mesh/D002547"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Paralysie cérébrale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Paralysie cérébrale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Paralysie cérébrale",
"description": "Comment diagnostique-t-on la paralysie cérébrale ?\nQuels tests sont utilisés pour le diagnostic ?\nÀ quel âge peut-on diagnostiquer la paralysie cérébrale ?\nQuels signes précoces indiquent une paralysie cérébrale ?\nLe diagnostic est-il toujours précis ?",
"url": "https://questionsmedicales.fr/mesh/D002547?mesh_terms=Muscle+Spasticity#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Paralysie cérébrale",
"description": "Quels sont les symptômes courants de la paralysie cérébrale ?\nLa paralysie cérébrale affecte-t-elle la parole ?\nY a-t-il des variations dans les symptômes ?\nLes enfants atteints ont-ils des problèmes d'apprentissage ?\nLes symptômes peuvent-ils s'aggraver avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D002547?mesh_terms=Muscle+Spasticity#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Paralysie cérébrale",
"description": "Peut-on prévenir la paralysie cérébrale ?\nQuel rôle joue la santé maternelle ?\nLes soins prénatals sont-ils importants ?\nComment éviter les traumatismes à la naissance ?\nLes vaccinations peuvent-elles aider ?",
"url": "https://questionsmedicales.fr/mesh/D002547?mesh_terms=Muscle+Spasticity#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Paralysie cérébrale",
"description": "Quels traitements sont disponibles pour la paralysie cérébrale ?\nLa chirurgie est-elle une option de traitement ?\nLes médicaments peuvent-ils aider ?\nComment la physiothérapie aide-t-elle ?\nLes traitements sont-ils personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D002547?mesh_terms=Muscle+Spasticity#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Paralysie cérébrale",
"description": "Quelles complications peuvent survenir ?\nLa paralysie cérébrale augmente-t-elle le risque d'autres maladies ?\nLes complications affectent-elles la qualité de vie ?\nComment gérer les complications ?\nLes complications sont-elles évitables ?",
"url": "https://questionsmedicales.fr/mesh/D002547?mesh_terms=Muscle+Spasticity#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Paralysie cérébrale",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge maternel influence-t-il le risque ?\nLes jumeaux ont-ils un risque plus élevé ?\nLes infections pendant la grossesse sont-elles un risque ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D002547?mesh_terms=Muscle+Spasticity#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la paralysie cérébrale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation clinique, l'historique médical et des examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests neurologiques, des évaluations motrices et parfois des IRM sont utilisés."
}
},
{
"@type": "Question",
"name": "À quel âge peut-on diagnostiquer la paralysie cérébrale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être diagnostiquée dès l'âge de 6 mois, mais souvent plus tard dans l'enfance."
}
},
{
"@type": "Question",
"name": "Quels signes précoces indiquent une paralysie cérébrale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des retards dans le développement moteur, une posture anormale ou des mouvements involontaires."
}
},
{
"@type": "Question",
"name": "Le diagnostic est-il toujours précis ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic peut être complexe et nécessite une observation prolongée des symptômes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de la paralysie cérébrale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles du mouvement, des spasmes musculaires et des problèmes d'équilibre."
}
},
{
"@type": "Question",
"name": "La paralysie cérébrale affecte-t-elle la parole ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des difficultés de communication et des troubles de la parole."
}
},
{
"@type": "Question",
"name": "Y a-t-il des variations dans les symptômes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes varient selon le type de paralysie cérébrale et la gravité."
}
},
{
"@type": "Question",
"name": "Les enfants atteints ont-ils des problèmes d'apprentissage ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains peuvent avoir des difficultés d'apprentissage, mais cela dépend de chaque cas."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils s'aggraver avec le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent évoluer, mais une intervention précoce peut aider à gérer la progression."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la paralysie cérébrale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines causes peuvent être évitées, comme les infections pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la santé maternelle ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne santé maternelle avant et pendant la grossesse réduit le risque de paralysie cérébrale."
}
},
{
"@type": "Question",
"name": "Les soins prénatals sont-ils importants ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins prénatals réguliers aident à détecter et à gérer les risques potentiels."
}
},
{
"@type": "Question",
"name": "Comment éviter les traumatismes à la naissance ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des soins obstétriques appropriés peuvent réduire le risque de traumatismes à la naissance."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations préviennent des infections qui pourraient causer des dommages cérébraux."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la paralysie cérébrale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la physiothérapie, l'orthophonie et parfois des médicaments."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option de traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chirurgie peut être envisagée pour corriger des déformations ou améliorer la fonction."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être prescrits pour réduire les spasmes musculaires et la douleur."
}
},
{
"@type": "Question",
"name": "Comment la physiothérapie aide-t-elle ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La physiothérapie améliore la mobilité, la force et la coordination des mouvements."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont adaptés aux besoins spécifiques de chaque patient."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des problèmes respiratoires, des troubles de l'alimentation et des infections."
}
},
{
"@type": "Question",
"name": "La paralysie cérébrale augmente-t-elle le risque d'autres maladies ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut augmenter le risque de maladies comme l'épilepsie et les troubles mentaux."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une approche multidisciplinaire est essentielle pour gérer les complications efficacement."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles évitables ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées avec un suivi médical approprié et des soins."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des naissances prématurées, des infections et des anomalies génétiques."
}
},
{
"@type": "Question",
"name": "L'âge maternel influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes plus âgées ont un risque accru de complications pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Les jumeaux ont-ils un risque plus élevé ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les naissances multiples augmentent le risque de paralysie cérébrale."
}
},
{
"@type": "Question",
"name": "Les infections pendant la grossesse sont-elles un risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections comme la rubéole peuvent augmenter le risque de paralysie cérébrale."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles neurologiques peuvent augmenter le risque."
}
}
]
}
]
}
From the Departments of Pediatrics and Neurology/Neurosurgery, McGill University; and Division of Pediatric Neurology, Montreal Children's Hospital-McGill University Health Centre, Canada. michael.shevell@muhc.mcgill.ca.
Faculty of Medicine (JPL), McGill University, Montreal, QC; Department of Pediatrics and Neurology and Neurosurgery (MO, MS), McGill University, Montreal, QC; Centre for Outcomes Research and Evaluation (MO, PN, MS), Research Institute of the McGill University Health Centre, Montreal, QC; Department of Pediatrics (JA), University of Alberta, Edmonton, AB; Janeway Children's Hospital (DB), St. John's, NL; Department of Paediatrics (DF), University of Toronto, Bloorview Research Institute, Toronto, ON; Departments of Pediatrics and Clinical Neurosciences (AK), Cumming School of Medicine, University of Calgary, AB; Centre de réadaptation Marie Enfant du CHU Sainte-Justine (LK), Montreal, QC; Centre hospitalier universitaire de Sherbrooke (NP), Sherbrooke, QC; BC Children's Hospital (EvR), Vancouver, BC; and IWK Health Centre (EW), Halifax, NS, Canada.
Division of Occupational Therapy and Physical Therapy, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 4007, Cincinnati, OH 45229, USA.
Faculty of Medicine (JPL), McGill University, Montreal, QC; Department of Pediatrics and Neurology and Neurosurgery (MO, MS), McGill University, Montreal, QC; Centre for Outcomes Research and Evaluation (MO, PN, MS), Research Institute of the McGill University Health Centre, Montreal, QC; Department of Pediatrics (JA), University of Alberta, Edmonton, AB; Janeway Children's Hospital (DB), St. John's, NL; Department of Paediatrics (DF), University of Toronto, Bloorview Research Institute, Toronto, ON; Departments of Pediatrics and Clinical Neurosciences (AK), Cumming School of Medicine, University of Calgary, AB; Centre de réadaptation Marie Enfant du CHU Sainte-Justine (LK), Montreal, QC; Centre hospitalier universitaire de Sherbrooke (NP), Sherbrooke, QC; BC Children's Hospital (EvR), Vancouver, BC; and IWK Health Centre (EW), Halifax, NS, Canada.
Faculty of Medicine (JPL), McGill University, Montreal, QC; Department of Pediatrics and Neurology and Neurosurgery (MO, MS), McGill University, Montreal, QC; Centre for Outcomes Research and Evaluation (MO, PN, MS), Research Institute of the McGill University Health Centre, Montreal, QC; Department of Pediatrics (JA), University of Alberta, Edmonton, AB; Janeway Children's Hospital (DB), St. John's, NL; Department of Paediatrics (DF), University of Toronto, Bloorview Research Institute, Toronto, ON; Departments of Pediatrics and Clinical Neurosciences (AK), Cumming School of Medicine, University of Calgary, AB; Centre de réadaptation Marie Enfant du CHU Sainte-Justine (LK), Montreal, QC; Centre hospitalier universitaire de Sherbrooke (NP), Sherbrooke, QC; BC Children's Hospital (EvR), Vancouver, BC; and IWK Health Centre (EW), Halifax, NS, Canada.
Faculty of Medicine (JPL), McGill University, Montreal, QC; Department of Pediatrics and Neurology and Neurosurgery (MO, MS), McGill University, Montreal, QC; Centre for Outcomes Research and Evaluation (MO, PN, MS), Research Institute of the McGill University Health Centre, Montreal, QC; Department of Pediatrics (JA), University of Alberta, Edmonton, AB; Janeway Children's Hospital (DB), St. John's, NL; Department of Paediatrics (DF), University of Toronto, Bloorview Research Institute, Toronto, ON; Departments of Pediatrics and Clinical Neurosciences (AK), Cumming School of Medicine, University of Calgary, AB; Centre de réadaptation Marie Enfant du CHU Sainte-Justine (LK), Montreal, QC; Centre hospitalier universitaire de Sherbrooke (NP), Sherbrooke, QC; BC Children's Hospital (EvR), Vancouver, BC; and IWK Health Centre (EW), Halifax, NS, Canada.
Faculty of Medicine (JPL), McGill University, Montreal, QC; Department of Pediatrics and Neurology and Neurosurgery (MO, MS), McGill University, Montreal, QC; Centre for Outcomes Research and Evaluation (MO, PN, MS), Research Institute of the McGill University Health Centre, Montreal, QC; Department of Pediatrics (JA), University of Alberta, Edmonton, AB; Janeway Children's Hospital (DB), St. John's, NL; Department of Paediatrics (DF), University of Toronto, Bloorview Research Institute, Toronto, ON; Departments of Pediatrics and Clinical Neurosciences (AK), Cumming School of Medicine, University of Calgary, AB; Centre de réadaptation Marie Enfant du CHU Sainte-Justine (LK), Montreal, QC; Centre hospitalier universitaire de Sherbrooke (NP), Sherbrooke, QC; BC Children's Hospital (EvR), Vancouver, BC; and IWK Health Centre (EW), Halifax, NS, Canada.
Division of Pediatric Neurology, Department of Neurology, School of Medicine, Washington University in St Louis and St Louis Children's Hospital, St Louis, Missouri; aravamuthanb@wustl.edu.
Division of Pediatric Neurology, Department of Neurology, School of Medicine, Washington University in St Louis and St Louis Children's Hospital, St Louis, Missouri.
Due to the heterogeneous clinical presentation of spastic cerebral palsy (SCP), which makes spasticity treatment challenging, more insight into the complex interaction between spasticity and altered m...
We studied associations between spasticity and muscle morphology and compared muscle morphology between commonly observed spasticity patterns (i.e. different muscle activation patterns during passive ...
Spasticity and muscle morphology of the medial gastrocnemius (MG) and semitendinosus (ST) were defined in 74 children with SCP (median age 8 years 2 months, GMFCS I/II/III: 31/25/18, bilateral/unilate...
A moderate negative association (r = -0.624, p < 0.001) was found between spasticity and MG muscle volume, while other significant associations between spasticity and muscle morphology parameters were...
Higher spasticity levels were associated with smaller MG and ST volumes and shorter MG muscles. These muscle morphology alterations were more pronounced in muscles that activated during low-velocity s...
To provide a comprehensive assessment of the treatment effects of nabiximols oromucosal spray on multiple sclerosis spasticity in two clinical trials, GWSP0604 and SAVANT....
Both studies enriched for responders before randomization, defined by a ≥20% improvement in Spasticity 0-10 numeric rating scale (NRS) score. Additionally, SAVANT used randomized re-titration followin...
Mean change from baseline in average daily Spasticity NRS scores was significantly larger for nabiximols than placebo at all postbaseline timepoints, ranging from -0.36 to -0.89 in GWSP0604 and -0.52 ...
Nabiximols leads to improvement in spasticity that was sustained over the 12-week treatment period as measured by average daily Spasticity NRS scores, daily spasm counts, and MAS scores for combinatio...
Upper limb spasticity and spasticity-induced deformities after upper motor neuron lesions because of traumatic brain injury, encephalitis or cerebral palsy inhibit activities of daily living, result i...
Evaluating muscle spasticity in children with cerebral palsy (CP) is essential for determining the most effective treatment strategies. This scoping review assesses the current methods used to evaluat...
A search (to April 2024) used keywords such as muscle spasticity, cerebral palsy, and assessment methods. Selection criteria included articles involving CP children, assessing spasticity objectively/s...
From an initial pool of 1971 articles, 30 met our inclusion criteria. These studies collectively appraised a variety of techniques ranging from well-established clinical scales like the modified Ashwo...
The review discussed the strengths and limitations of each method and concluded that more reliable methods are needed to measure the level of muscle spasticity more accurately....
Spasticity is prevalent following Traumatic Brain Injury. 'Focal' muscle spasticity has been defined as spasticity affecting a localised muscle group, but it's impact on gait kinetics remains unclear....
Ninety-three participants attending physiotherapy for mobility limitations following Traumatic Brain Injury were invited to participate in the study. Participants underwent clinical gait analysis and ...
Hip extensor power generation at initial contact, hip flexor power generation at terminal stance, and knee extensor power absorption at terminal stance were all significantly increased, and ankle powe...
Focal muscle spasticity had little association with abnormal gait kinetics in this cohort of independently ambulant people with Traumatic Brain Injury....
To investigate the influence of muscle position (relaxed vs stretched) on muscle mechanical properties and the ability of myotonometry to detect differences between sides, groups, and sites of testing...
Cross-sectional study....
Outpatient rehabilitation units including private and public centers....
Seventy-one participants (20 subacute stroke, 20 chronic stroke, 31 controls) were recruited (N=71)....
Muscle mechanical properties were measured bilaterally with a MyotonPRO at muscle belly and musculotendinous sites during 2 protocols (muscle relaxed or in maximal bearable stretched position)....
Muscle tone and stiffness of the biceps brachii and gastrocnemius. Poststroke spasticity was evaluated with the Modified Tardieu Scale (MTS). A mixed-model analysis of variance was used to detect diff...
The analysis of variance showed a significant effect of muscle position on muscle mechanical properties (higher tone and stiffness with the muscle assessed in stretched position). Measurements with th...
Myotonometry assessment of mechanical properties with the muscle stretched improves the ability of myotonometry to discriminate between sides in patients after stroke and between people with and witho...
In cerebral palsy (CP), spasticity is the dominant symptom and hip pain is one of the most common secondary conditions. Aetiology is not clear. Musculoskeletal ultrasound (MSUS) is a low-cost, non-inv...
A retrospective case-matched-control study. To investigate associated factors with painful spastic hip and to compare ultrasound findings (focusing on muscle thickness) in children with CP vs. typical...
Paediatric Rehabilitation Hospital in Mexico City, from August to November 2018....
21 children (13 male, 7 + 4.26 years) with CP, in Gross Motor Function Classification System (GMFCS) levels IV to V, with spastic hip diagnosis (cases) and 21 children age- and sex-matched (7 + 4.28 y...
Sociodemographic data, CP topography, degree of spasticity, mobility arch, contractures, Visual Analog Scale (VAS), GMFCS, measurements of the volumes of eight major muscles of the hip joint and MSUS ...
All children with CP group reported chronic hip pain. Associated factors for hip pain (high VAS hip pain score) were degree of hip displacement (percentage of migration), Ashworth Level, GMFCS level V...
Though possibly the most important issue with diminished muscle growth in CP children is the influence on their long-term function, it is likely that training routines that build muscle size may also ...
Botulinum neurotoxin-A (BoNT-A) injections are effective for focal spasticity. However, the impact on muscle strength is not established. This study aimed to investigate the effect of BoNT-A injection...
Although reduced gait asymmetry and trunk control are generally accepted outcomes in stroke patients after having a stroke, the number of studies examining the factors affecting gait symmetry and trun...
What are the effects of gastrocnemius muscle spasticity on trunk control and gait symmetry in chronic stroke patients?...
The sample of the study included 29 individuals aged 40-70 who were diagnosed with stroke at least six months ago. The sociodemographic information of the patients was collected using a descriptive in...
There was a numerical difference between the gait symmetry results of the patients who had a MAS score lower than 2 and those who had a MAS score of 2 or higher, where MAS scores corresponded to gastr...
According to the results of our study, to improve trunk control and gait in stroke survivors, the management of gastrocnemius muscle spasticity should be included in rehabilitation programs. We believ...
Evaluation the effects of dry needling on sonographic, biomechanical and functional parameters of spastic upper extremity muscles....
Twenty-four patients (35-65 years) with spastic hand were randomly allocated into two equal groups: intervention and sham-controlled groups. The treatment protocol was 12-sessions neurorehabilitation ...
The analysis showed that there was a significant reduction in muscle thickness, spasticity and reflex torque and a significant increment in motor function and dexterity in both groups after treatment ...
Dry needling plus neurorehabilitation could decrease muscle thickness, spasticity and reflex torque and improve upper-extremity motor performance and dexterity in chronic stroke patients. These change...